Lidovara by Oncora Pharma, LLC LIDOVARA gel

Lidovara by

Drug Labeling and Warnings

Lidovara by is a Prescription medication manufactured, distributed, or labeled by Oncora Pharma, LLC. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

DESCRIPTION

Lidovara™ is a topical gel containing Lidocaine Hydrochloride 28 mg/g (2.8%).

INDICATIONS AND USAGE

Lidovara™ is indicated for topical analgesia as directed by a healthcare provider.

CONTRAINDICATIONS

Lidovara™ is contraindicated in patients with known hypersensitivity to lidocaine or any component of the formulation.

WARNINGS

For external use only. Not for ophthalmic use.

Avoid contact with eyes.

Excessive application may result in increased systemic absorption.

Keep out of reach of children.

OVERDOSAGE

Excessive topical application may result in increased systemic absorption of lidocaine. In the event of overdose, discontinue use and seek medical attention.

DOSAGE AND ADMINISTRATION

For topical use only.

Apply to the affected area 3 to 4 times daily or as directed by a healthcare provider.

HOW SUPPLIED

Lidovara™ (Lidocaine Hydrochloride 28 mg/g) is supplied as a clear topical gel in a 3.5 oz (100 g) tube.

NDC: 85477-303-07

PRINCIPAL DISPLAY PANEL

pdp

INGREDIENTS AND APPEARANCE

LIDOVARA 
lidovara gel

Product Information
Product Type	HUMAN PRESCRIPTION DRUG	Item Code (Source)	NDC: 85477-303
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987)	LIDOCAINE	28 mg  in 1 g

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
HYDROXYETHYLCELLULOSE (UNII: T4V6TWG28D)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)
SODIUM HYDROXIDE (UNII: 55X04QC32I)
LACTIC ACID (UNII: 33X04XA5AT)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 85477-303-07	100 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product	02/26/2026

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		02/26/2026

Labeler - Oncora Pharma, LLC (119482542)